Pure Global

BIOMERIEUX SA - Authorized Company ProfileBIOMERIEUX SA

Explore comprehensive authorized company profile for BIOMERIEUX SA through Pure Global AI's free Colombia medical device database. This company manufactures 108 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Jan 27, 2022 to Sep 11, 2033.

This page provides detailed insights including recent registrations, risk class distribution (I: 40, III: 10, IIa: 5, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
108 Devices
5 Risk Classes
BIOMERIEUX SA
BIOMERIEUX SA
Authorized Company
108
Total Devices
5
Risk Classes
2022
Earliest
2033
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

VIDAS NT-PROBNP2

NT-PROBNP2 LIVES

d3a0bc13eb7ddf3199bd2d3cfd6dea4e

II
Sep 11, 2033

VIDAS KUBE CLINICAL - ANALIZADOR DE INMUNOENSAYO VIDAS KUBE CLINICAL

VIDAS KUBE CLINICAL - VIDAS KUBE CLINICAL IMMUNOASSAY ANALYZER

47674738fffbe5e39f22509f90e1a297

IIa
Jun 06, 2033

BIOFIRE JOINT INFECTION (JI) PANEL

BIOFIRE JOINT INFECTION (JI) PANEL

2cfb1527651e2b901c3d1eebfcdf4a9c

II
May 26, 2033

FOSFOMYCIN

FOSFOMYCIN

cfd6aa1ba749189b97a8bc3ffc0faeae

II
Feb 28, 2033

SALINE SOLUTION

SALINE SOLUTION

2c5851d1b6663b15798233c0d5cc91a2

I
Jan 31, 2033

CEFUROXIME

CEFUROXIME

ea921179304f710bc0db5bf2ad98b95b

II
Jan 01, 2033

AMOXICILLIN/CLAVULANIC ACID (2/1)

AMOXICILLIN/CLAVULANIC ACID (2/1)

77e1fff3b55cc90b6d8d605e7629b7aa

II
Dec 27, 2032

1. AST-N271

1. AST-N271

83dbd3edc34339b387443314a0d92a6e

II
Nov 30, 2032

1. BACT/ALERT FA PLUS

1. BACT/ALERT FA PLUS

ba5aeb92c51c513dde19dafd297cb9f0

I
Aug 04, 2032

VITEK - ANALIZADOR PARA MICROBIOLOGIA VITEK SERIE MS

VITEK - ANALYZER FOR VITEK MICROBIOLOGY MS SERIES

01ac777925cc9012f2a55f11d40cec5b

IIa
Jul 01, 2032

1. ATB HAEMO CLSI (12)

1. ATB HAEMO CLSI (12)

269c8f0e3b43f7698bf6fa5162b2c1e1

I
Jul 01, 2032

VIDAS ANTI-TPO

VIDAS ANTI-TPO

3945d4d7973e4ff33d397e9f7b98f7f4

II
Jun 16, 2032

CHROMID P. AERUGINOSA AGAR

CHROMID P. AERUGINOSA AGAR

db024aecf1b676311348561a2734f2f9

I
Jun 16, 2032

CHROMID VIBRIO AGAR

CHROMID VIBRIO AGAR

8c3fd165a6bbe8147fbcef2fb80d5a6f

I
Jan 10, 2032

ETEST IMIPENEM / RELEBACTAM (IPR)

ETEST IMIPENEM / RELEBACTAM (IPR)

c298186436e3c33b3ebe76975b116d31

Sep 02, 2031

ETEST MEROPENEM / MEROPENEM + EDTA

ETEST MEROPENEM / MEROPENEM + EDTA

eb1bcbf5f2f887347164495d6e13fc60

II
Sep 02, 2031

VIDAS NEPHROCHECK (NEPH)

NEPHROCHECK LIVES (NEPH)

c0a7c4ccc83c1d8d025fe07bff343845

II
Jun 29, 2031

VITEK 2 0.45 % SODIUM CHLORIDE DILUENT

VITEK 2 0.45 % SODIUM CHLORIDE DILUENT

487c2df0e83a93952619660d3d13756c

I
Jun 28, 2031

TODD HEWITT BROTH + ANTIBIOTICS

TODD HEWITT BROTH + ANTIBIOTICS

88cb52cd0ca1d38044079688239c182f

I
Apr 12, 2031

CAMPYLOSEL AGAR

CAMPYLOSEL AGAR

5a34cb2241a942508520364370fb21d6

Apr 12, 2031
Risk Class Distribution
Devices by risk class
II
49
45.4% of total
I
40
37.0% of total
III
10
9.3% of total
IIa
5
4.6% of total
Unspecified
4
3.7% of total